{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:55:19Z","timestamp":1791921319758,"version":"4.3.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AG079336"],"award-info":[{"award-number":["AG079336"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AG057842"],"award-info":[{"award-number":["AG057842"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM104357"],"award-info":[{"award-number":["P20GM104357"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R35ES030443"],"award-info":[{"award-number":["R35ES030443"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U54NS127758"],"award-info":[{"award-number":["U54NS127758"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["5P42ES004699"],"award-info":[{"award-number":["5P42ES004699"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012127","name":"Augusta University","doi-asserted-by":"publisher","award":["TRIBA Faculty Startup Fund"],"award-info":[{"award-number":["TRIBA Faculty Startup Fund"]}],"id":[{"id":"10.13039\/100012127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018576","name":"Harrington Discovery Institute, University Hospitals","doi-asserted-by":"publisher","award":["A25-1690"],"award-info":[{"award-number":["A25-1690"]}],"id":[{"id":"10.13039\/100018576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["25PRE1365157"],"award-info":[{"award-number":["25PRE1365157"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01550-8","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:01:20Z","timestamp":1738627280000},"page":"4429-4449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer's disease and diabetes-related dementia rat models"],"prefix":"10.1007","volume":"47","author":[{"given":"Chengyun","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane J.","family":"Border","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yedan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert C.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhania","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Cantwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Morisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Min","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"O\u2019Herron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Bagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Filosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-3610","authenticated-orcid":false,"given":"Fan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"1550_CR1","doi-asserted-by":"publisher","unstructured":"2023 Alzheimer's disease facts and figures. Alzheimers Dement. 2023;19:1598\u2013695. https:\/\/doi.org\/10.1002\/alz.13016.","DOI":"10.1002\/alz.13016"},{"key":"1550_CR2","doi-asserted-by":"publisher","unstructured":"2024 Alzheimer's disease facts and figures. Alzheimers Dement. 2024;20:3708\u2013821. https:\/\/doi.org\/10.1002\/alz.13809.","DOI":"10.1002\/alz.13809"},{"key":"1550_CR3","doi-asserted-by":"crossref","unstructured":"Huang LK, Chao SP, Hu CJ. Clinical trials of new drugs for Alzheimer disease. J Biomed Sci. 2020;27:18.","DOI":"10.1186\/s12929-019-0609-7"},{"key":"1550_CR4","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s11357-022-00591-7","volume":"44","author":"X Fang","year":"2022","unstructured":"Fang X, Zhang J, Roman RJ, Fan F. From 1901 to 2022, how far are we from truly understanding the pathogenesis of age-related dementia? GeroScience. 2022;44:1879\u201383.","journal-title":"GeroScience"},{"key":"1550_CR5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1177\/0271678X20982383","volume":"41","author":"O Bracko","year":"2021","unstructured":"Bracko O, Cruz Hern\u00e1ndez JC, Park L, Nishimura N, Schaffer CB. Causes and consequences of baseline cerebral blood flow reductions in Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2021;41:1501\u201316.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1550_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00401-020-02215-w","volume":"140","author":"N Korte","year":"2020","unstructured":"Korte N, Nortley R, Attwell D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer\u2019s disease. Acta Neuropathol. 2020;140:793\u2013810.","journal-title":"Acta Neuropathol"},{"key":"1550_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s11357-021-00357-7","volume":"43","author":"F Fan","year":"2021","unstructured":"Fan F, Roman RJ. Reversal of cerebral hypoperfusion: a novel therapeutic target for the treatment of AD\/ADRD? Geroscience. 2021;43:1065\u20137.","journal-title":"Geroscience"},{"key":"1550_CR8","doi-asserted-by":"publisher","unstructured":"Fang X, Tang C, Zhang H, Border JJ, Liu Y, Shin SM, Yu H, Roman RJ, Fan F. Longitudinal characterization of cerebral hemodynamics in the TgF344-AD rat model of Alzheimer's disease. Geroscience. 2023. https:\/\/doi.org\/10.1007\/s11357-023-00773-x.","DOI":"10.1007\/s11357-023-00773-x"},{"key":"1550_CR9","doi-asserted-by":"publisher","first-page":"953.7","DOI":"10.1096\/fasebj.30.1_supplement.953.7","volume":"30","author":"F Fan","year":"2016","unstructured":"Fan F, Pabbidi M, Lin RCS, Ge Y, Gomez-Sanchez EP, Rajkowska GK, Moulana M, Gonzalez-fernandez E, Sims J, Elliott MR, Paul IA, Alexander AP, Mosley TH, Harder DR, Roman RJ. Impaired myogenic response of MCA elevates transmission of pressure to penetrating arterioles and contributes to cerebral vascular disease in aging hypertensive FHH rats. FASEB J. 2016;30:953.7-953.7.","journal-title":"FASEB J."},{"key":"1550_CR10","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2741\/4465","volume":"21","author":"F Fan","year":"2016","unstructured":"Fan F, Ge Y, Lv W, Elliott MR, Muroya Y, Hirata T, Booz GW, Roman RJ. Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology. Front Biosci (Landmark Ed). 2016;21:1427\u201363.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1550_CR11","first-page":"149","volume":"2","author":"R Crumpler","year":"2021","unstructured":"Crumpler R, Roman RJ, Fan F. Capillary stalling: a mechanism of decreased cerebral blood flow in AD\/ADRD. J Exp Neurol. 2021;2:149\u201353.","journal-title":"J Exp Neurol"},{"key":"1550_CR12","doi-asserted-by":"publisher","first-page":"9158","DOI":"10.18632\/aging.202963","volume":"13","author":"F Fan","year":"2021","unstructured":"Fan F, Booz GW, Roman RJ. Aging diabetes, deconstructing the cerebrovascular wall. Aging (Albany NY). 2021;13:9158\u20139.","journal-title":"Aging (Albany NY)"},{"key":"1550_CR13","doi-asserted-by":"publisher","unstructured":"Wang S, Tang C, Liu Y, Border JJ, Roman RJ and Fan F. Impact of impaired cerebral blood flow autoregulation on cognitive impairment. Front Aging. 2022;3:1077302. https:\/\/doi.org\/10.3389\/fragi.2022.1077302.","DOI":"10.3389\/fragi.2022.1077302"},{"key":"1550_CR14","doi-asserted-by":"publisher","unstructured":"Fang X, Crumpler RF, Thomas KN, Mazique JN, Roman RJ and Fan F. Contribution of cerebral microvascular mechanisms to age-related cognitive impairment and dementia. Physiol Int. 2022. https:\/\/doi.org\/10.1556\/2060.2022.00020.","DOI":"10.1556\/2060.2022.00020"},{"key":"1550_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2018;4:575\u201390.","journal-title":"Alzheimers Dement (N Y)"},{"key":"1550_CR16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41380-021-01361-1","volume":"27","author":"CE Finger","year":"2022","unstructured":"Finger CE, Moreno-Gonzalez I, Gutierrez A, Moruno-Manchon JF, McCullough LD. Age-related immune alterations and cerebrovascular inflammation. Mol Psychiatry. 2022;27:803\u201318.","journal-title":"Mol Psychiatry"},{"key":"1550_CR17","doi-asserted-by":"publisher","first-page":"ATP556","DOI":"10.1161\/str.50.suppl_1.TP556","volume":"50","author":"S Wang","year":"2019","unstructured":"Wang S, Jiao F, Guo Y, Booz G, Roman R, Fan F. Role of vascular smooth muscle cells in diabetes-related vascular cognitive impairment. Stroke. 2019;50:ATP556\u2013ATP556.","journal-title":"Stroke."},{"key":"1550_CR18","doi-asserted-by":"publisher","first-page":"H1219","DOI":"10.1152\/ajpheart.00722.2019","volume":"318","author":"S Wang","year":"2020","unstructured":"Wang S, Zhang H, Liu Y, Li L, Guo Y, Jiao F, Fang X, Jefferson JR, Li M, Gao W, Gonzalez-Fernandez E, Maranon RO, Pabbidi MR, Liu R, Alexander BT, Roman RJ, Fan F. Sex differences in the structure and function of rat middle cerebral arteries. Am J Physiol Heart Circ Physiol. 2020;318:H1219\u201332.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"1550_CR19","doi-asserted-by":"publisher","first-page":"H989","DOI":"10.1152\/ajpheart.00636.2013","volume":"306","author":"MR Pabbidi","year":"2014","unstructured":"Pabbidi MR, Mazur O, Fan F, Farley JM, Gebremedhinm D, Harder DR, Roman RJ. Enhanced large conductance K+ channel (BK) activity contributes to the impaired myogenic response in the cerebral vasculature of Fawn Hooded Hypertensive rats. Am J Physiol Heart Circ Physiol. 2014;306(7):H989\u20131000.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"1550_CR20","doi-asserted-by":"publisher","first-page":"102993","DOI":"10.1016\/j.isci.2021.102993","volume":"24","author":"JA Aguilar-Pineda","year":"2021","unstructured":"Aguilar-Pineda JA, Vera-Lopez KJ, Shrivastava P, Ch\u00e1vez-Fumagalli MA, Nieto-Montesinos R, Alvarez-Fernandez KL, Goyzueta Mamani LD, Davila Del-Carpio G, Gomez-Valdez B, Miller CL, Malhotra R, Lindsay ME, Lino Cardenas CL. Vascular smooth muscle cell dysfunction contribute to neuroinflammation and Tau hyperphosphorylation in Alzheimer disease. IScience. 2021;24:102993.","journal-title":"IScience."},{"key":"1550_CR21","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.3390\/ijms24087117","volume":"24","author":"X Xu","year":"2023","unstructured":"Xu X, Liu XQ, Liu XL, Wang X, Zhang WD, Huang XF, Jia FY, Kong P, Han M. SM22\u03b1 deletion contributes to neurocognitive impairment in mice through modulating vascular smooth muscle cell phenotypes. Int J Mol Sci. 2023;24:7117.","journal-title":"Int J Mol Sci."},{"key":"1550_CR22","doi-asserted-by":"publisher","first-page":"106548","DOI":"10.1016\/j.prostaglandins.2021.106548","volume":"154","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang H, Wu CY, Yu T, Fang X, Ryu JJ, Zheng B, Chen Z, Roman RJ, Fan F. 20-HETE-promoted cerebral blood flow autoregulation is associated with enhanced pericyte contractility. Prostaglandins Other Lipid Mediat. 2021;154:106548.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1550_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11357-020-00179-z","volume":"42","author":"Y Guo","year":"2020","unstructured":"Guo Y, Wang S, Liu Y, Fan L, Booz GW, Roman RJ, Chen Z, Fan F. Accelerated cerebral vascular injury in diabetes is associated with vascular smooth muscle cell dysfunction. Geroscience. 2020;42:547\u201361.","journal-title":"Geroscience"},{"key":"1550_CR24","doi-asserted-by":"publisher","first-page":"H549","DOI":"10.1152\/ajpheart.00726.2020","volume":"320","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang H, Wang S, Guo Y, Fang X, Zheng B, Gao W, Yu H, Chen Z, Roman RJ, Fan F. Reduced pericyte and tight junction coverage in old diabetic rats are associated with hyperglycemia-induced cerebrovascular pericyte dysfunction. Am J Physiol Heart Circ Physiol. 2021;320:H549\u201362.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1550_CR25","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1007\/s11357-023-00841-2","volume":"45","author":"X Fang","year":"2023","unstructured":"Fang X, Border JJ, Rivers PL, Zhang H, Williams JM, Fan F, Roman RJ. Amyloid beta accumulation in TgF344-AD rats is associated with reduced cerebral capillary endothelial Kir2.1 expression and neurovascular uncoupling. Geroscience. 2023;45:2909\u201326.","journal-title":"Geroscience"},{"key":"1550_CR26","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s11357-020-00233-w","volume":"42","author":"S Wang","year":"2020","unstructured":"Wang S, Lv W, Zhang H, Liu Y, Li L, Jefferson JR, Guo Y, Li M, Gao W, Fang X, Paul IA, Rajkowska G, Shaffery JP, Mosley TH, Hu X, Liu R, Wang Y, Yu H, Roman RJ, Fan F. Aging exacerbates impairments of cerebral blood flow autoregulation and cognition in diabetic rats. Geroscience. 2020;42:1387\u2013410.","journal-title":"Geroscience"},{"key":"1550_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","volume":"53","author":"C Morisseau","year":"2013","unstructured":"Morisseau C, Hammock BD. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol. 2013;53:37\u201358.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1550_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1369\/jhc.2008.950659","volume":"56","author":"P Sura","year":"2008","unstructured":"Sura P, Sura R, Enayetallah AE, Grant DF. Distribution and expression of soluble epoxide hydrolase in human brain. J Histochem Cytochem. 2008;56:551\u20139.","journal-title":"J Histochem Cytochem"},{"key":"1550_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.neuroscience.2009.06.033","volume":"163","author":"A Marowsky","year":"2009","unstructured":"Marowsky A, Burgener J, Falck JR, Fritschy JM, Arand M. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism. Neuroscience. 2009;163:646\u201361.","journal-title":"Neuroscience"},{"key":"1550_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.atherosclerosis.2006.02.021","volume":"190","author":"Q Wei","year":"2007","unstructured":"Wei Q, Doris PA, Pollizotto MV, Boerwinkle E, Jacobs DR Jr, Siscovick DS, Fornage M. Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking. Atherosclerosis. 2007;190:26\u201334.","journal-title":"Atherosclerosis"},{"key":"1550_CR31","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/sj.jcbfm.9600494","volume":"27","author":"W Zhang","year":"2007","unstructured":"Zhang W, Koerner IP, Noppens R, Grafe M, Tsai HJ, Morisseau C, Luria A, Hammock BD, Falck JR, Alkayed NJ. Soluble epoxide hydrolase: a novel therapeutic target in stroke. J Cereb Blood Flow Metab. 2007;27:1931\u201340.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1550_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fphar.2019.00018","volume":"10","author":"\u0160 Vackov\u00e1","year":"2019","unstructured":"Vackov\u00e1 \u0160, Kopkan L, Kikerlov\u00e1 S, Huskov\u00e1 Z, Sadowski J, Kompanowska-Jezierska E, Hammock BD, Imig JD, T\u00e1borsk\u00fd M, Melenovsk\u00fd V, \u010cervenka L. Pharmacological blockade of soluble epoxide hydrolase attenuates the progression of congestive heart failure combined with chronic kidney disease: insights from studies with fawn-hooded hypertensive rats. Front Pharmacol. 2019;10:18.","journal-title":"Front Pharmacol"},{"key":"1550_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41419-020-2594-x","volume":"11","author":"X-S Jiang","year":"2020","unstructured":"Jiang X-S, Xiang X-Y, Chen X-M, He J-l, Liu T, Gan H, Du X-G. Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy. Cell Death Dis. 2020;11:385.","journal-title":"Cell Death Dis"},{"key":"1550_CR34","doi-asserted-by":"publisher","first-page":"E5815","DOI":"10.1073\/pnas.1802179115","volume":"115","author":"Q Ren","year":"2018","unstructured":"Ren Q, Ma M, Yang J, Nonaka R, Yamaguchi A, Ishikawa KI, Kobayashi K, Murayama S, Hwang SH, Saiki S, Akamatsu W, Hattori N, Hammock BD, Hashimoto K. Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2018;115:E5815-e5823.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1550_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12035-017-0726-9","volume":"55","author":"HJ Huang","year":"2018","unstructured":"Huang HJ, Wang YT, Lin HC, Lee YH, Lin AM. Soluble epoxide hydrolase inhibition attenuates MPTP-induced neurotoxicity in the nigrostriatal dopaminergic system: involvement of \u03b1-Synuclein aggregation and ER stress. Mol Neurobiol. 2018;55:138\u201344.","journal-title":"Mol Neurobiol"},{"key":"1550_CR36","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1021\/jm100691c","volume":"53","author":"TE Rose","year":"2010","unstructured":"Rose TE, Morisseau C, Liu JY, Inceoglu B, Jones PD, Sanborn JR, Hammock BD. 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain. J Med Chem. 2010;53:7067\u201375.","journal-title":"J Med Chem"},{"key":"1550_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","volume":"180","author":"KM Wagner","year":"2017","unstructured":"Wagner KM, McReynolds CB, Schmidt WK, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. Pharmacol Ther. 2017;180:62\u201376.","journal-title":"Pharmacol Ther"},{"key":"1550_CR38","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1021\/acs.jmedchem.0c01886","volume":"64","author":"BD Hammock","year":"2021","unstructured":"Hammock BD, McReynolds CB, Wagner K, Buckpitt A, Cortes-Puch I, Croston G, Lee KSS, Yang J, Schmidt WK, Hwang SH. Movement to the clinic of soluble epoxide hydrolase inhibitor EC5026 as an analgesic for neuropathic pain and for use as a nonaddictive opioid alternative. J Med Chem. 2021;64:1856\u201372.","journal-title":"J Med Chem"},{"key":"1550_CR39","doi-asserted-by":"publisher","first-page":"e12653","DOI":"10.1111\/micc.12653","volume":"28","author":"N Matin","year":"2021","unstructured":"Matin N, Fisher C, Lansdell TA, Hammock BD, Yang J, Jackson WF, Dorrance AM. Soluble epoxide hydrolase inhibition improves cognitive function and parenchymal artery dilation in a hypertensive model of chronic cerebral hypoperfusion. Microcirculation. 2021;28:e12653.","journal-title":"Microcirculation"},{"key":"1550_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainres.2018.07.002","volume":"1699","author":"J Hao","year":"2018","unstructured":"Hao J, Chen Y, Yao E, Liu X. Soluble epoxide hydrolase inhibition alleviated cognitive impairments via NRG1\/ErbB4 signaling after chronic cerebral hypoperfusion induced by bilateral carotid artery stenosis in mice. Brain Res. 2018;1699:89\u201399.","journal-title":"Brain Res"},{"key":"1550_CR41","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1126\/scitranslmed.abb1206","volume":"12","author":"A Ghosh","year":"2020","unstructured":"Ghosh A, Comerota MM, Wan D, Chen F, Propson NE, Hwang SH, Hammock BD, Zheng H. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2020;12:5733.","journal-title":"Sci Transl Med."},{"key":"1550_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.prostaglandins.2015.06.005","volume":"121","author":"AI Ostermann","year":"2015","unstructured":"Ostermann AI, Herbers J, Willenberg I, Chen R, Hwang SH, Greite R, Morisseau C, Gueler F, Hammock BD, Schebb NH. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern. Prostaglandins Other Lipid Mediat. 2015;121:131\u20137.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1550_CR43","doi-asserted-by":"publisher","unstructured":"Islam O, Patil P, Goswami SK, Razdan R, Inamdar MN, Rizwan M, Mathew J, Inceoglu B, Stephen Lee KS, Hwang SH, Hammock BD. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats. Cardiovasc Ther. 2017;35(3). https:\/\/doi.org\/10.1111\/1755-5922.12259.","DOI":"10.1111\/1755-5922.12259"},{"key":"1550_CR44","doi-asserted-by":"publisher","first-page":"H246","DOI":"10.1152\/ajpheart.00438.2021","volume":"322","author":"S Wang","year":"2022","unstructured":"Wang S, Jiao F, Border JJ, Fang X, Crumpler RF, Liu Y, Zhang H, Jefferson J, Guo Y, Elliott PS, Thomas KN, Strong LB, Urvina AH, Zheng B, Rijal A, Smith SV, Yu H, Roman RJ, Fan F. Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals. Am J Physiol Heart Circ Physiol. 2022;322:H246\u201359.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1550_CR45","doi-asserted-by":"publisher","first-page":"e14345","DOI":"10.14814\/phy2.14345","volume":"8","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhang C, Liu Y, Gao W, Wang S, Fang X, Guo Y, Li M, Liu R, Roman RJ, Sun P, Fan F. Influence of dual-specificity protein phosphatase 5 on mechanical properties of rat cerebral and renal arterioles. Physiol Rep. 2020;8:e14345.","journal-title":"Physiol Rep"},{"key":"1550_CR46","doi-asserted-by":"publisher","first-page":"A15835","DOI":"10.1161\/circ.148.suppl_1.15835","volume":"148","author":"C Tang","year":"2023","unstructured":"Tang C, Zhang H, Border JJ, Hammock BD, Roman RJ, Fan F. Abstract 15835: inhibition of soluble epoxide hydrolase reduces cognitive impairment and improves cerebral hemodynamics in AD\/ADRD. Circulation. 2023;148:A15835\u2013A15835.","journal-title":"Circulation"},{"key":"1550_CR47","doi-asserted-by":"publisher","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads.\u00a0EMBnet. journal. 2011;17(1):10\u20132.\u00a0https:\/\/doi.org\/10.14806\/ej.17.1.200.","DOI":"10.14806\/ej.17.1.200"},{"key":"1550_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"1550_CR49","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1550_CR50","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X, Yu G. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2:100141.","journal-title":"Innovation (Camb)."},{"key":"1550_CR51","doi-asserted-by":"publisher","first-page":"F971","DOI":"10.1152\/ajprenal.00529.2016","volume":"312","author":"F Fan","year":"2017","unstructured":"Fan F, Pabbidi MR, Ge Y, Li L, Wang S, Mims PN, Roman RJ. Knockdown of Add3 impairs the myogenic response of renal afferent arterioles and middle cerebral arteries. Am J Physiol Renal Physiol. 2017;312:F971\u201381.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1550_CR52","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1007\/s11357-024-01061-y","volume":"46","author":"C Tang","year":"2024","unstructured":"Tang C, Zhang H, Border JJ, Liu Y, Fang X, Jefferson JR, Gregory A, Johnson C, Lee TJ, Bai S, Sharma A, Shin SM, Yu H, Roman RJ, Fan F. Impact of knockout of dual-specificity protein phosphatase 5 on structural and mechanical properties of rat middle cerebral arteries: implications for vascular aging. Geroscience. 2024;46:3135\u201347.","journal-title":"Geroscience"},{"key":"1550_CR53","doi-asserted-by":"publisher","first-page":"e82482","DOI":"10.1371\/journal.pone.0082482","volume":"8","author":"F Fan","year":"2013","unstructured":"Fan F, Sun CW, Maier KG, Williams JM, Pabbidi MR, Didion SP, Falck JR, Zhuo J, Roman RJ. 20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K+ channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels. PLoS ONE. 2013;8:e82482.","journal-title":"PLoS ONE"},{"key":"1550_CR54","doi-asserted-by":"publisher","first-page":"F509","DOI":"10.1152\/ajprenal.00273.2014","volume":"307","author":"Y Ge","year":"2014","unstructured":"Ge Y, Murphy SR, Fan F, Williams JM, Falck JR, Liu R, Roman RJ. Role of 20-HETE in the impaired myogenic and TGF responses of the Af-Art of Dahl salt-sensitive rats. Am J Physiol Renal Physiol. 2014;307:F509\u201315.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1550_CR55","doi-asserted-by":"publisher","first-page":"F565","DOI":"10.1152\/ajprenal.00404.2012","volume":"304","author":"M Burke","year":"2013","unstructured":"Burke M, Pabbidi M, Fan F, Ge Y, Liu R, Williams JM, Sarkis A, Lazar J, Jacob HJ, Roman RJ. Genetic basis of the impaired renal myogenic response in FHH rats. Am J Physiol Renal Physiol. 2013;304:F565\u201377.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1550_CR56","doi-asserted-by":"publisher","first-page":"R379","DOI":"10.1152\/ajpregu.00256.2014","volume":"308","author":"F Fan","year":"2015","unstructured":"Fan F, Geurts AM, Murphy SR, Pabbidi MR, Jacob HJ, Roman RJ. Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat. Am J Physiol Regul Integr Comp Physiol. 2015;308:R379\u201390.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1550_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.RES.66.1.8","volume":"66","author":"FM Faraci","year":"1990","unstructured":"Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res. 1990;66:8\u201317.","journal-title":"Circ Res"},{"key":"1550_CR58","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/01.RES.59.2.216","volume":"59","author":"WG Mayhan","year":"1986","unstructured":"Mayhan WG, Heistad DD. Role of veins and cerebral venous pressure in disruption of the blood-brain barrier. Circ Res. 1986;59:216\u201320.","journal-title":"Circ Res"},{"key":"1550_CR59","doi-asserted-by":"publisher","unstructured":"Pires PW, Dabertrand F, Earley S. Isolation and Cannulation of Cerebral Parenchymal Arterioles. J Vis Exp. 2016;111:53835. https:\/\/doi.org\/10.3791\/53835.","DOI":"10.3791\/53835"},{"key":"1550_CR60","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1152\/physrev.00022.2020","volume":"101","author":"J Claassen","year":"2021","unstructured":"Claassen J, Thijssen DHJ, Panerai RB, Faraci FM. Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation. Physiol Rev. 2021;101:1487\u2013559.","journal-title":"Physiol Rev."},{"key":"1550_CR61","first-page":"555587","volume":"2","author":"S Shekhar","year":"2017","unstructured":"Shekhar S, Wang S, Mims PN, Gonzalez-Fernandez E, Zhang C, He X, Liu CY, Lv W, Wang Y, Huang J, Fan F. Impaired cerebral autoregulation-a common neurovascular pathway in diabetes may play a critical role in diabetes-related alzheimer\u2019s disease. Curr Res Diabetes Obes J. 2017;2:555587.","journal-title":"Curr Res Diabetes Obes J"},{"key":"1550_CR62","doi-asserted-by":"publisher","unstructured":"Huang LK, Kuan YC, Lin HW, Hu CJ. Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update. J Biomed Sci. 2023;30(1):83. https:\/\/doi.org\/10.1186\/s12929-023-00976-6.","DOI":"10.1186\/s12929-023-00976-6"},{"key":"1550_CR63","doi-asserted-by":"publisher","first-page":"862369","DOI":"10.3389\/fneur.2022.862369","volume":"13","author":"CG Withington","year":"2022","unstructured":"Withington CG, Turner RS. Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to alzheimer\u2019s disease. Front Neurol. 2022;13:862369.","journal-title":"Front Neurol"},{"issue":"15","key":"1550_CR64","first-page":"321","volume":"2019","author":"J Gaugler","year":"2019","unstructured":"Gaugler J, James B, Johnson T, Marin A, Weuve J, As A. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2019;2019(15):321\u201387.","journal-title":"Alzheimers Dement"},{"key":"1550_CR65","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s11357-013-9613-0","volume":"36","author":"K Samaras","year":"2014","unstructured":"Samaras K, Lutgers HL, Kochan NA, Crawford JD, Campbell LV, Wen W, Slavin MJ, Baune BT, Lipnicki DM, Brodaty H, Trollor JN, Sachdev PS. The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study. Age (Dordr). 2014;36:977\u201393.","journal-title":"Age (Dordr)"},{"key":"1550_CR66","unstructured":"Wang S, Mims PN, Roman RJ and Fan F. Is Beta-Amyloid Accumulation a Cause or Consequence of Alzheimer's Disease? J Alzheimers Parkinsonism Dement. 2016;11(2):007."},{"key":"1550_CR67","doi-asserted-by":"publisher","first-page":"AP243","DOI":"10.1161\/hyp.68.suppl_1.p243","volume":"68","author":"W Lv","year":"2016","unstructured":"Lv W, Yu H, Li L, Taylor C, Gonzalez-Fernandez E, Sims J, Elliott MR, Wang Y, Williams JM, Roman RJ, Fan F. Abstract P243: a new type 2 diabetic rat model that is associated with cognitive impairment in aging. Hypertension. 2016;68:AP243\u2013AP243.","journal-title":"Hypertension."},{"key":"1550_CR68","doi-asserted-by":"publisher","unstructured":"Tang C, Border JJ, Zhang H, Gregory A, Bai S, Fang X, Liu Y, Wang S, Hwang SH, Gao W, Morgan GC, Smith J, Bunn D, Cantwell C, Wagner KM, Morisseau C, Yang J, Shin SM, O\u2019Herron P, Bagi Z, Filosa JA, Dong Y, Yu H, Hammock BD, Roman RJ, Fan F. Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer\u2019s disease and diabetes-related dementia rat models. bioRxiv. 2024:2024.08.30.610540. https:\/\/doi.org\/10.1101\/2024.08.30.610540.","DOI":"10.1101\/2024.08.30.610540"},{"key":"1550_CR69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/bs.apha.2016.04.003","volume":"77","author":"JD Imig","year":"2016","unstructured":"Imig JD. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function. Adv Pharmacol. 2016;77:105\u201341.","journal-title":"Adv Pharmacol"},{"key":"1550_CR70","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nm0597-562","volume":"3","author":"MF Moghaddam","year":"1997","unstructured":"Moghaddam MF, Grant DF, Cheek JM, Greene JF, Williamson KC, Hammock BD. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nat Med. 1997;3:562\u20136.","journal-title":"Nat Med"},{"key":"1550_CR71","doi-asserted-by":"publisher","first-page":"108484","DOI":"10.1016\/j.jnutbio.2020.108484","volume":"86","author":"K Hildreth","year":"2020","unstructured":"Hildreth K, Kodani SD, Hammock BD, Zhao L. Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies. J Nutr Biochem. 2020;86:108484.","journal-title":"J Nutr Biochem"},{"key":"1550_CR72","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s13311-020-00854-1","volume":"17","author":"C Gri\u00f1\u00e1n-Ferr\u00e9","year":"2020","unstructured":"Gri\u00f1\u00e1n-Ferr\u00e9 C, Codony S, Pujol E, Yang J, Leiva R, Escolano C, Puigoriol-Illamola D, Companys-Alemany J, Corpas R, Sanfeliu C, P\u00e9rez B, Loza MI, Brea J, Morisseau C, Hammock BD, V\u00e1zquez S, Pall\u00e0s M, Galdeano C. Pharmacological inhibition of soluble epoxide hydrolase as a new therapy for alzheimer\u2019s disease. Neurotherapeutics. 2020;17:1825\u201335.","journal-title":"Neurotherapeutics"},{"key":"1550_CR73","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12974-019-1635-9","volume":"16","author":"HT Lee","year":"2019","unstructured":"Lee HT, Lee KI, Chen CH, Lee TS. Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer\u2019s disease. J Neuroinflammation. 2019;16:267.","journal-title":"J Neuroinflammation"},{"key":"1550_CR74","doi-asserted-by":"publisher","first-page":"112516","DOI":"10.1016\/j.fct.2021.112516","volume":"156","author":"CP Sun","year":"2021","unstructured":"Sun CP, Zhang XY, Zhou JJ, Huo XK, Yu ZL, Morisseau C, Hammock BD, Ma XC. Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer\u2019s disease through GSK3\u03b2 signaling pathway. Food Chem Toxicol. 2021;156:112516.","journal-title":"Food Chem Toxicol"},{"key":"1550_CR75","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s12975-018-0672-5","volume":"10","author":"D Yu","year":"2019","unstructured":"Yu D, Hennebelle M, Sahlas DJ, Ramirez J, Gao F, Masellis M, Cogo-Moreira H, Swartz RH, Herrmann N, Chan PC, Pettersen JA, Stuss DT, Black SE, Taha AY, Swardfager W. Soluble epoxide hydrolase-derived linoleic acid oxylipins in serum are associated with periventricular white matter hyperintensities and vascular cognitive impairment. Transl Stroke Res. 2019;10:522\u201333.","journal-title":"Transl Stroke Res"},{"key":"1550_CR76","unstructured":"Fan F, Simino J, Auchus AP, Knopman DS, Boerwinkle E, Fornage M, Mosley TH, Roman RJ. Functional variants in CYP4A11 and CYP4F2 are associated with cognitive impairment and related dementia endophenotypes in the elderly. In: The 16th International Winter Eicosanoid Conference; Baltimore. 2016."},{"key":"1550_CR77","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1021\/acschemneuro.9b00271","volume":"10","author":"Z Liang","year":"2019","unstructured":"Liang Z, Zhang B, Xu M, Morisseau C, Hwang SH, Hammock BD, Li QX. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a selective and potent dual inhibitor of soluble epoxide hydrolase and p38 kinase intervenes in alzheimer\u2019s signaling in human nerve cells. ACS Chem Neurosci. 2019;10:4018\u201330.","journal-title":"ACS Chem Neurosci"},{"key":"1550_CR78","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.prostaglandins.2018.05.004","volume":"136","author":"N Minaz","year":"2018","unstructured":"Minaz N, Razdan R, Hammock BD, Goswami SK. An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats. Prostaglandins Other Lipid Mediat. 2018;136:84\u20139.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1550_CR79","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fphar.2019.00288","volume":"10","author":"R Pardeshi","year":"2019","unstructured":"Pardeshi R, Bolshette N, Gadhave K, Arfeen M, Ahmed S, Jamwal R, Hammock BD, Lahkar M, Goswami SK. Docosahexaenoic acid increases the potency of soluble epoxide hydrolase inhibitor in alleviating streptozotocin-induced alzheimer\u2019s disease-like complications of diabetes. Front Pharmacol. 2019;10:288.","journal-title":"Front Pharmacol"},{"key":"1550_CR80","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/ejn.15150","volume":"53","author":"J Wu","year":"2021","unstructured":"Wu J, Fan Z, Zhao Y, Chen Q, Xiao Q. Inhibition of soluble epoxide hydrolase (sEH) protects hippocampal neurons and reduces cognitive decline in type 2 diabetic mice. Eur J Neurosci. 2021;53:2532\u201340.","journal-title":"Eur J Neurosci"},{"key":"1550_CR81","doi-asserted-by":"publisher","first-page":"100667","DOI":"10.1016\/j.jbc.2021.100667","volume":"296","author":"J Luo","year":"2021","unstructured":"Luo J, Hu S, Fu M, Luo L, Li Y, Li W, Cai Y, Dong R, Yang Y, Tu L, Xu X. Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney. J Biol Chem. 2021;296:100667.","journal-title":"J Biol Chem"},{"key":"1550_CR82","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1073\/pnas.1103482108","volume":"108","author":"A Luria","year":"2011","unstructured":"Luria A, Bettaieb A, Xi Y, Shieh GJ, Liu HC, Inoue H, Tsai HJ, Imig JD, Haj FG, Hammock BD. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc Natl Acad Sci U S A. 2011;108:9038\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1550_CR83","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejphar.2010.12.016","volume":"654","author":"LN Zhang","year":"2011","unstructured":"Zhang LN, Vincelette J, Chen D, Gless RD, Anandan SK, Rubanyi GM, Webb HK, MacIntyre DE, Wang YX. Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension. Eur J Pharmacol. 2011;654:68\u201374.","journal-title":"Eur J Pharmacol"},{"key":"1550_CR84","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/HYPERTENSIONAHA.121.17659","volume":"78","author":"JM Luther","year":"2021","unstructured":"Luther JM, Ray J, Wei D, Koethe JR, Hannah L, DeMatteo A, Manning R, Terker AS, Peng D, Nian H, Yu C, Mashayekhi M, Gamboa J, Brown NJ. GSK2256294 decreases sEH (Soluble Epoxide Hydrolase) activity in plasma, muscle, and adipose and reduces F2-isoprostanes but does not alter insulin sensitivity in humans. Hypertension. 2021;78:1092\u2013102.","journal-title":"Hypertension"},{"key":"1550_CR85","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1021\/acs.biochem.7b00794","volume":"56","author":"R Liu","year":"2017","unstructured":"Liu R, Hossain MM, Chen X, Jin JP. Mechanoregulation of SM22\u03b1\/Transgelin. Biochemistry. 2017;56:5526\u201338.","journal-title":"Biochemistry"},{"key":"1550_CR86","doi-asserted-by":"publisher","first-page":"e13921","DOI":"10.1371\/journal.pone.0013921","volume":"5","author":"H Shao","year":"2010","unstructured":"Shao H, Wang JH, Pollak MR, Wells A. \u03b1-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. PLoS ONE. 2010;5:e13921.","journal-title":"PLoS ONE"},{"key":"1550_CR87","doi-asserted-by":"publisher","first-page":"F97","DOI":"10.1152\/ajprenal.00423.2020","volume":"320","author":"W Gao","year":"2021","unstructured":"Gao W, Liu Y, Fan L, Zheng B, Jefferson JR, Wang S, Zhang H, Fang X, Nguyen BV, Zhu T, Roman RJ, Fan F. Role of \u03b3-adducin in actin cytoskeleton rearrangements in podocyte pathophysiology. Am J Physiol Renal Physiol. 2021;320:F97-f113.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1550_CR88","doi-asserted-by":"publisher","first-page":"C1277","DOI":"10.1152\/ajpcell.1999.277.6.C1277","volume":"277","author":"AS Lader","year":"1999","unstructured":"Lader AS, Kwiatkowski DJ, Cantiello HF. Role of gelsolin in the actin filament regulation of cardiac L-type calcium channels. Am J Physiol. 1999;277:C1277\u201383.","journal-title":"Am J Physiol"},{"key":"1550_CR89","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.apsb.2021.01.005","volume":"11","author":"Q Yu","year":"2021","unstructured":"Yu Q, Wu C, Chen Y, Li B, Wang R, Huang R, Li X, Gu D, Wang X, Duan X, Li S, Liu Y, Wu W, Hennenberg M, Zeng G. Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle. Acta Pharm Sin B. 2021;11:1914\u201330.","journal-title":"Acta Pharm Sin B"},{"key":"1550_CR90","doi-asserted-by":"publisher","first-page":"593966","DOI":"10.3389\/fphys.2020.593966","volume":"11","author":"J Sun","year":"2020","unstructured":"Sun J, Qiao YN, Tao T, Zhao W, Wei LS, Li YQ, Wang W, Wang Y, Zhou YW, Zheng YY, Chen X, Pan HC, Zhang XN, Zhu MS. Distinct roles of smooth muscle and non-muscle myosin light chain-mediated smooth muscle contraction. Front Physiol. 2020;11:593966.","journal-title":"Front Physiol"},{"key":"1550_CR91","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1152\/physiolgenomics.00111.2010","volume":"42a","author":"SA Fisher","year":"2010","unstructured":"Fisher SA. Vascular smooth muscle phenotypic diversity and function. Physiol Genomics. 2010;42a:169\u201387.","journal-title":"Physiol Genomics."},{"key":"1550_CR92","doi-asserted-by":"publisher","first-page":"1053457","DOI":"10.3389\/fimmu.2022.1053457","volume":"13","author":"Z Lin","year":"2022","unstructured":"Lin Z, Shi JL, Chen M, Zheng ZM, Li MQ, Shao J. CCL2: An important cytokine in normal and pathological pregnancies: A review. Front Immunol. 2022;13:1053457.","journal-title":"Front Immunol"},{"key":"1550_CR93","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2005.11.061","volume":"397","author":"ME Munguia","year":"2006","unstructured":"Munguia ME, Govezensky T, Martinez R, Manoutcharian K, Gevorkian G. Identification of amyloid-beta 1\u201342 binding protein fragments by screening of a human brain cDNA library. Neurosci Lett. 2006;397:79\u201382.","journal-title":"Neurosci Lett"},{"key":"1550_CR94","doi-asserted-by":"crossref","unstructured":"Reza K, Mostafa R-T, Bahareh T, Sadegh A. Multi-regional Neurodegeneration in Alzheimer\u2019s disease: meta-analysis and data integration of transcriptomics data. bioRxiv. 2018;245571.","DOI":"10.1101\/245571"},{"key":"1550_CR95","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13041-019-0430-y","volume":"12","author":"SS Adav","year":"2019","unstructured":"Adav SS, Park JE, Sze SK. Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer\u2019s disease. Mol Brain. 2019;12:8.","journal-title":"Mol Brain"},{"key":"1550_CR96","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/2211-5463.12484","volume":"8","author":"M Bianchi","year":"2018","unstructured":"Bianchi M, Crinelli R, Arbore V, Magnani M. Induction of ubiquitin C (UBC) gene transcription is mediated by HSF1: role of proteotoxic and oxidative stress. FEBS Open Bio. 2018;8:1471\u201385.","journal-title":"FEBS Open Bio"},{"key":"1550_CR97","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","volume":"33","author":"RM Cohen","year":"2013","unstructured":"Cohen RM, Rezai-Zadeh K, Weitz TM, Rentsendorj A, Gate D, Spivak I, Bholat Y, Vasilevko V, Glabe CG, Breunig JJ, Rakic P, Davtyan H, Agadjanyan MG, Kepe V, Barrio JR, Bannykh S, Szekely CA, Pechnick RN, Town T. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a\u03b2, and frank neuronal loss. J Neurosci. 2013;33:6245\u201356.","journal-title":"J Neurosci"},{"key":"1550_CR98","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/FJC.0b013e3181506445","volume":"50","author":"N Chiamvimonvat","year":"2007","unstructured":"Chiamvimonvat N, Ho CM, Tsai HJ, Hammock BD. The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J Cardiovasc Pharmacol. 2007;50:225\u201337.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1550_CR99","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1161\/01.STR.28.2.405","volume":"28","author":"MJ Cipolla","year":"1997","unstructured":"Cipolla MJ, Porter JM, Osol G. High glucose concentrations dilate cerebral arteries and diminish myogenic tone through an endothelial mechanism. Stroke. 1997;28:405\u201311.","journal-title":"Stroke"},{"key":"1550_CR100","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12868-020-00596-y","volume":"21","author":"CE O\u2019Brien","year":"2020","unstructured":"O\u2019Brien CE, Santos PT, Kulikowicz E, Lee JK, Koehler RC, Martin LJ. Neurologic effects of short-term treatment with a soluble epoxide hydrolase inhibitor after cardiac arrest in pediatric swine. BMC Neurosci. 2020;21:43.","journal-title":"BMC Neurosci"},{"key":"1550_CR101","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.4103\/NRR.NRR-D-24-00503","volume":"20","author":"A Gregory","year":"2025","unstructured":"Gregory A, Tang C, Fan F. Soluble epoxide hydrolase: a next-generation drug target for Alzheimer\u2019s disease and related dementias. Neural Regen Res. 2025;20:2585\u20136.","journal-title":"Neural Regen Res"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01550-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01550-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01550-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T10:02:19Z","timestamp":1750500139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01550-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1550"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01550-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.30.610540","asserted-by":"object"}]},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants have consented to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"B.D. Hammock is a founder and S.H. Hwang, and J. Yang are employees of EicOsis L.L.C., a startup company with an sEH inhibitor in human clinical trials.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}